These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11207041

  • 1. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.
    Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E.
    Br J Cancer; 2001 Feb; 84(4):478-81. PubMed ID: 11207041
    [Abstract] [Full Text] [Related]

  • 2. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E.
    Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492
    [Abstract] [Full Text] [Related]

  • 3. The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients.
    Chen-Shtoyerman R, Figer A, Fidder HH, Rath P, Yeremin L, Bar Meir S, Friedman E, Theodor L.
    Br J Cancer; 2001 Feb; 84(4):475-7. PubMed ID: 11207040
    [Abstract] [Full Text] [Related]

  • 4. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 5. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.
    Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903
    [Abstract] [Full Text] [Related]

  • 6. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E.
    Hum Mutat; 2000 Dec 01; 16(6):491-501. PubMed ID: 11102978
    [Abstract] [Full Text] [Related]

  • 7. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May 01; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetic analyses in consecutive israeli jewish colorectal cancer patients.
    Fidder HH, Figer A, Geva R, Flex D, Schayek H, Avidan B, Meir SB, Friedman E.
    Am J Gastroenterol; 2005 Jun 01; 100(6):1376-80. PubMed ID: 15929773
    [Abstract] [Full Text] [Related]

  • 11. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
    Clin Cancer Res; 2002 Dec 01; 8(12):3776-81. PubMed ID: 12473589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer.
    Gershoni-Baruch R, Dagan E, Fried G, Kepten I, Robinson E.
    Eur J Hum Genet; 1999 Dec 01; 7(7):833-6. PubMed ID: 10573018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history.
    Beller U, Halle D, Catane R, Kaufman B, Hornreich G, Levy-Lahad E.
    Gynecol Oncol; 1997 Nov 01; 67(2):123-6. PubMed ID: 9367693
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
    Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V.
    Neoplasma; 2006 Nov 01; 53(2):97-102. PubMed ID: 16575464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.